Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Methotrexate-albumin conjugate may be particularly useful against prostate cancer, sarcomas

July 25, 2001

QLT and Novartis Ophthalmics expand verteporfin codevelopment agreement

July 25, 2001

FDA advisory committee to review IntraDose

July 25, 2001

Cell Matrix awarded grants for development of novel antiangiogenesis products

July 25, 2001

Patient enrollment completed in SafeScience phase II pancreatic cancer trial

July 24, 2001

VEGF inhibitors useful for angiogenesis-related disorders according to Yamanouchi

July 24, 2001

Vion's Triapine enters phase II for treatment of leukemia

July 24, 2001

Patient enrollment completed in phase I trial of Inex's INX-3280

July 24, 2001

FDA Oncologic Drugs Advisory Committee to review Zevalin at upcoming meeting

July 24, 2001

NeoOncoRx completes acquisition of Neoquin; phase II trials to commence in U.K.

July 24, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 22, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 22, 2025.
In 2025, science’s biggest story was political
BioWorld
In 2025, science saw its breakthroughs, which BioWorld will be covering as part of our end-of-the-year wrap-up. But the biggest science story of 2025 is not about...
FDA says yes to Cytokinetics’ aficamten, now Myqorzo, in oHCM
BioWorld
Cytokinetics Inc. scored U.S. FDA marketing clearance Dec. 19 for Myqorzo (aficamten) 5-mg, 10-mg, 15-mg, and 20-mg tablets to improve functional capacity and...
Conjugating ferrocene to GPX4 inhibitors to promote ferroptosis
BioWorld Science
Small molecules that induce iron-dependent oxidative cell death known as ferroptosis can be effective against tumors that are resistant to other therapies....